Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de David Reese
Age : 59
Public asset : 12,642,439 USD
Country of residence : Unknown
Linked companies : Amgen Inc.

Biography of David Reese 
Founder of Translational Oncology Research International, Inc., David M. Reese is Executive Vice President-Research & Development at Amgen, Inc. Dr. Reese previously held the position of Director-Clinical Research at Breast Cancer International Research Group Ltd. and Director-Clinical Research at Translational Research In Oncology. He received an undergraduate degree from Harvard College and an undergraduate degree from The University of Cincinnati College of Medicine.


Current positions of David Reese 
Holdings of David Reese 
David Reese : Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/26LVMH's Arnault brushes off succession question
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
01/26Wells Fargo CEO Scharf's 2022 pay unchanged at $24.5 million
RE
More news


© 2023 People and Ownership :   
David Reese : Connections 


Latest news about David Reese 
01/13Drug companies favor biotech meds over pills, citing new U.S. law
RE
2022Amgen Inc., Horizon Therapeutics Public Limited Company - M&A Call
CI
2022Transcript : Amgen Inc. - Special Call
CI
2022Transcript : Amgen Inc. Presents at 20(th) WCIRDC Hybrid Conference, Dec-03-2022
CI
2022Transcript : Amgen Inc. Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 11:20 AM
CI
2022Transcript : Amgen Inc. Presents at Credit Suisse 31st Annual Healthcare Conference, Nov-09-2022 12:50 PM
CI
More news